Berberine · 120 capsules
- Numerous effects
- Scientifically proven
- High dosage
- 150 mg berberine per capsule
- Easy to dose capsule form
- Proven quality - Made in Germany
Nährwerte und Inhaltsstoffe
Composition | per capsule |
---|---|
Berberine hydrochloride | 150 mg |
Zutaten: Chinese golden threadroot extract (95% berberine HCL), coating agent: hydroxypropyl methylcellulose (vegetable capsule shell), bulking agent: microcrystalline cellulose.
*Prozent der empfohlenen täglichen Verzehrmenge laut Verordnung (EU) Nr. 1196/2011
**Keine Nährstoffbezugswerte (NRV) vorhanden.
Verzehrempfehlung
Take 1 capsule daily unchewed with plenty of water.
Hinweise
Hersteller / Distributor
GN Laboratories Europe, London / United Kingdom
Nero Labs BV, Postbus 278, 5900AG Venlo, The Netherlands
Quellen
- Kulkarni, S. K., & Dhir, A. (2010). Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytotherapy Research, 24(3), 317-324.
- Yin, J., Xing, H., Ye, J., & Efficacy, S. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 57(5), 712-717.
- Kong, W. J., Wei, J., Abidi, P., Lin, M. H., Inaba, S., Li, C., ... & Li, Y. C. (2004). Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature medicine, 10(12), 1344-1351.
- Zhang, Y., Li, X. J., Yan, F. F., & Sun, H. R. (2010). The effects of berberine on hepatic LDLR mRNA and protein expression in rats with non-alcoholic fatty liver disease. Pharmaceutical biology, 48(3), 315-321.
- Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., ... & Ning, G. (2008). Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. The Journal of Clinical Endocrinology & Metabolism, 93(7), 2559-2565.
- Dong, H., Wang, N., Zhao, L., & Lu, F. (2012). Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine, 2012.
- Yin, J., Ye, J., Jia, W., & Efficacy, S. (2008). Effects and mechanisms of berberine in diabetes treatment. Acta Pharmacologica Sinica, 29(10), 1149-1163.
- Wang, Y., & Campbell, T. (2017). Berberine enhances insulin receptor signaling and modifies gene expression of glucose metabolism, inflammation, and mitochondrial biogenesis in culturing human skeletal muscle cells. Evidence-Based Complementary and Alternative Medicine, 2017.
- Kong WJ, Wei J, Zuo ZY, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004;10(12):1344-1351. doi:10.1038/nm1135
- Derosa, G., Maffioli, P., & Cicero, A. F. (2015). Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opinion on Biological Therapy, 15(9), 1297-1306.
- Wu, X., Li, Q., Xin, H., Yu, A., Zhong, M., & Guo, X. (2017). Anti-inflammatory and antibacterial activity of berberine in an infected pressure ulcer model. Molecular Medicine Reports, 16(2), 1297-1303.
- Sun, X., & Lv, F. (2015). Berberine: pathway validation and drug discovery. Expert Opinion on Drug Discovery, 10(10), 1033-1044.
- Dong, H., Wang, N., Zhao, L., Lu, F. E., & Xu, L. J. (2012). Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evidence-based complementary and alternative medicine, 2012, 591654. https://doi.org/10.1155/2012/591654
- Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012). AMP-activated protein kinase: a target for drugs both ancient and modern. Chemistry & biology, 19(10), 1222-1236. https://doi.org/10.1016/j.chembiol.2012.08.019
- Wu, L., Xia, M., Duan, Y., Zhang, L., Jiang, H., Hu, X., Yan, H., Zhang, Y., Gu, J., & Xiang, S. (2014). Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans. Cell death & disease, 5(2), e1306. https://doi.org/10.1038/cddis.2014.274
- Chang, W., Zhang, M., Li, J., Meng, Z., Wei, S., Du, H., & Zhang, Y. (2013). Berberine improves insulin resistance in cardiomyocytes via activation of 5′-adenosine monophosphate-activated protein kinase. Metabolism, 62(8), 1159-1167. https://doi.org
- Yin, J., Xing, H., Ye, J., & Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized controlled trials. Phytotherapy research : PTR, 2019. https://doi.org/10.1002/ptr.6549
- Lan, J., Zhao, Y., Dong, F., Yan, Z., Zheng, W., Fan, J., Sun, G. (2015). Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. Journal of Ethnopharmacology, 161, 69-81. https://doi.org/10.1016/j.jep.2014.09.049
- Huang, X., Liu, G., Guo, J., Su, Z. (2015). The PI3K/Akt pathway mediates the anti-apoptotic effect of berberine in the rat remnant kidney model. International Journal of Molecular Sciences, 16(2), 3092-3105. doi: 10.3390/ijms16023092
- Wang Y, Huang Y, Lam KS. Berberine and its derivatives: a patent review (2009-2012). Expert Opin Ther Pat. 2012;22(8):969-984.
- Gerard J, Soriano García J, Romo-Mancillas A, González-Cortazar M, Guzmán-Grenfell AM, Sánchez-Sevilla L. Effect of Berberine on Inflammatory and Oxidative Stress Markers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Antioxidants (Basel). 2021;10(2):282. doi: 10.3390/antiox10020282. PMID: 33673056; PMCID: PMC7914246.
Inhalt: 120 capsules Artikelnr.: 6792